BMC Med Genomics. 2018 Aug 09;11(1):65
Association of Metabolic, Inflammatory, and Tumor Markers With Circulating Tumor Cells in Metastatic Breast Cancer.
JNCI Cancer Spectr. 2018 Apr;2(2):pky028
Ther Innov Regul Sci. 2018 Jan 01;:2168479018784910
Oncology education for Canadian internal medicine residents: the value of participating in a medical oncology elective rotation.
Curr Oncol. 2018 Jun;25(3):213-218
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.
BMJ Open. 2018 Apr 26;8(4):e021876
Cancer Causes Control. 2018 Apr 20;:
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2018 Feb 05;:
Breast Cancer Res Treat. 2017 Nov 24;:
Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC).
J Clin Oncol. 2011 Mar;29(7_suppl):241
Phase II study of MKC-1 in patients with metastatic or resistant epithelial ovarian cancer or advanced endometrial cancer.
J Clin Oncol. 2009 May 20;27(15_suppl):5577